AccelStor Smashes Performance Barriers with NeoSapphire All-Flash Array
AccelStor, the software-defined all-flash array provider, will be demonstrating its NeoSapphire H710 all-flash array at SC17 (SuperComputing 2017) for high performance computing solutions. The advantage of the NeoSapphire series and the advanced AccelStor FlexiRemap® technology is making HPC applications simpler and more efficient with its powerful performance and impressive scalability. The latest H710 will be showcased during SC17, at booth #1972, at the Colorado Convention Center, Denver, USA from November 13-17, 2017.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171109005019/en/
The NeoSapphire H710 packs over 600K sustained IOPS for 4KB random writes, ideal for HPC applications. (Photo: Business Wire)
SC17 is the premier international conference showcasing the many aspects of high performance computing, networking, storage and analysis leading to advances in scientific discovery, research, education and commerce. HPC (High-Performance Computing) specifically refers to running advanced applications efficiently and reliably. The high performance and true high availability design of the NeoSapphire H710 all-flash array makes it the perfect solution for HPC systems. Furthermore, the exclusive FlexiRemap® technology enables the all-flash array to meet the most complicated of data-access demands, making it best-suited for HPC applications.
AccelStor Vice President, David Kao, said “We are thrilled about our latest NeoSapphire H710. It’s designed to unleash the true performance of flash technology, and remove bottlenecks, enabling a seamless system experience, easy installation, computing efficiency, scalability and faster time to results. The most common demand and need for HPC comes from scientific researchers, engineers and academic institutions. For our customers who desire extreme-scale computing, reliability and high availability, they will definitely benefit from the NeoSapphire H710.”
Sustained High IOPS Performance
Real-world HPC applications need more than high, “peak” performance. As flash appliances often provide high-speed, shared storage services to multiple front-end compute nodes, high sustained IOPS is the real driver in flash storage performance for I/O-intensive HPC applications. Thanks to the award-winning FlexiRemap® technology, and its patented data handling algorithm, is specifically designed just for flash memory and it can outperform competitors when dealing with the most complicated 4KB random write data access, even under dramatically heavy workloads. The NeoSapphire H710 packs over 600K sustained IOPS for 4KB random writes in a single 4U rack over standard 10GbE or 16G Fibre Channel LC SFP+ network interfaces.
Low Operating Expenses and Rich Data Service Tools
AccelStor’s high availability (HA) flash storage solution address the challenges operators face by enabling them to improve the reliability and reduce high OPEX (Operating Expenses). The NeoSapphire High Availability AFA delivers world-class reliability. Based on a shared-nothing architecture and redundant hardware design, this model uses enterprise SSDs with a long lifespan suitable for write-intensive workload applications. The NeoSapphire product range features a rich suite of software features and performance-boosting technology, including Free Clone, thin provisioning, thick provisioning and FlexiDedupe™ pre-bundled with each system. In order to provide the best redundancy and data protection, the H710 also comes with Remote Replication, Redirect-on-Write Snapshot, Snapshot Backup/Recovery and Group Snapshot for database usage as standard.
Scalability and High Availability
AccelStor helps clients achieve a competitive business advantage by delivering sustained performance of 600K IOPS at 4KB random write, reliability and scalability. Customers frequently experience an imbalance of capacity and performance as business grows, enterprises will feel the pain of compromises, caused by unpredictable costs of adding capacity and falling performance. The NeoSapphire H710 supports on-demand scale-up from a basic 27TB in 4U rack to a max. 221TB in 12U rack. Its shared-nothing architecture with FlexiRemap® technology also ensures no single point of failure, no data loss and essentially no downtime.
Download the NeoSapphire
H710 Product Sheet
Learn more about the NeoSapphire all-flash array high-availability series
Learn more about FlexiRemap® Technology
Follow AccelStor on Twitter: @AccelStor
Follow AccelStor on Linkedin
About AccelStor, Inc.
AccelStor is accelerating the paradigm shift from conventional disk arrays to modern all-flash storage. AccelStor's NeoSapphire all-flash arrays, powered by FlexiRemap software technology, deliver sustained high IOPS for business-critical applications. With streamlined storage management, multi-protocol support, and front-access, hot-swappable solid-state drives, the NeoSapphire series promises to resolve performance bottlenecks for I/O-intensive applications like artificial intelligence, IoT, data center, virtualization, high-performance computing, database, media processing, fintech and gaming. For more information about AccelStor and NeoSapphire, please visit www.accelstor.com.
AccelStor, FlexiRemap and NeoSapphire are trademarks or registered trademarks of AccelStor, Inc. in the United States of America and/or other countries.
* IOPS test results mentioned in this press release are generated by AccelStor and may vary in different test environments.
Clara Lee, +886 2 77467616 ext. 2561
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
CT-P13 (biosimilar infliximab) is comparable to reference infliximab and adalimumab in highly anticipated real-world study17.2.2018 11:00 | Tiedote
Twelve-month data from the Personalised Anti-TNF therapy in Crohn’s disease Study (PANTS) was presented at the 13th Congress of the European Crohn’s and Colitis Organisation (ECCO). The results indicate that the clinical effectiveness, safety and immunogenicity of Celltrion Healthcare’s CT-P13 (biosimilar infliximab) in patients with Crohn’s disease (CD) is comparable to those treated with reference infliximab as well as those treated with adalimumab.1 The UK-wide, three-year prospective observational study investigated primary non-response (PNR), loss of response (LOR) and adverse drug reactions (ADR) to infliximab (reference infliximab and CT-P13) and adalimumab in 1610 CD patients. The data show comparable efficacy between CT-P13, reference infliximab and adalimumab in relation to PNR, LOR and ADR rates. In addition, at week 54, the remission rate was 39.7%, 39.0% and 32.7% for reference infliximab, CT-P13 and adalimumab treated patients, respectively.1 The PANTS study investigates
Avanti Communications HYLAS 4 Satellite Arrives in French Guiana16.2.2018 21:26 | Tiedote
Avanti Communications Group plc (“Avanti”), a leading provider of satellite data communications services in Europe, the Middle East and Africa (“EMEA”), announces its HYLAS 4 satellite has arrived safely in French Guiana ahead of its March 2018 launch. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005586/en/ Avanti Communications HYLAS 4 Satellite Arrives in French Guiana (Photo: Business Wire) The spacecraft, built by Orbital ATK was packed and shipped at their Satellite Manufacturing Facility in Dulles, Virginia, United States and flown to French Guiana, where it was unloaded and will be taken to the Arianespace launch facilities in Kourou. HYLAS 4 uses the latest High Throughput Satellite technology, doubling Avanti's Ka-band capacity across EMEA. The latest addition to Avanti's HYLAS fleet will provide: Backhaul services for mobile network operators Wholesale broadband for ISPs Connectivity for governments (civil a
General Cable Corporation Stockholders Approve Acquisition By Prysmian Group16.2.2018 20:05 | Tiedote
General Cable Corporation (NYSE: BGC) today announced the voting results from the Company’s special meeting of stockholders held this morning. Stockholders of General Cable approved the Company’s previously announced acquisition by Prysmian Group (BIT: PRY) for $30.00 per share in cash. A total of 38,140,754 shares, representing approximately 75.34% of the total number of shares of common stock outstanding and approximately 99% of the total votes cast, were voted in favor of the merger. Subject to regulatory approvals and other customary closing conditions, the transaction is expected to close by the third quarter of 2018. About General Cable General Cable (NYSE:BGC), with headquarters in Highland Heights, Kentucky, is a global leader in the development, design, manufacture, marketing and distribution of aluminum, copper and fiber optic wire and cable products for the energy, communications, automotive, industrial, construction and specialty segments. General Cable is one of the larges
Systemic Sclerosis World Congress:Inspirational Patient Stories Reveal the Challenging Realities of Living with Devastating Rare Disease16.2.2018 12:03 | Tiedote
Boehringer Ingelheim today unveils a new phase of 'More Than Scleroderma: The Inside Story', and launches the new patient website www.morethanscleroderma.com. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005188/en/ Anna, 36, living with scleroderma (Photo: Business Wire) The global initiative highlights the importance of understanding the ‘inside story’ of each individual living with scleroderma, also known as systemic sclerosis. To coincide with the Systemic Sclerosis World Congress in Bordeaux, 15-17 February 2018, new and truly inspiring patient stories are revealed, reflecting the real-life, diverse and very moving journeys of people living with scleroderma across the world. The campaign will also be launched in the U.S. The new website www.morethanscleroderma.com features a powerful collection of photographs and video stories of people living with scleroderma across the world, revealing the life-changing impact o
Philip Morris International Recognized as a Global Top Employer for the Second Year in a Row16.2.2018 11:00 | Tiedote
Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today is recognized for the second year in a row as a Global Top Employer. This year’s certification from the Top Employer Institute is awarded to PMI teams in 44 countries, a testament to the company’s consistency and excellence in offering an enriching and dynamic work environment, and exceptional development opportunities for employees across the globe. PMI has been recognized by the Top Employer Institute for six consecutive years. This year, PMI was awarded with five regional certifications in Europe, the Middle East, Africa and, for the first time, in North America and Latin America. Additionally, Indonesia was the first PMI affiliate to be certified in Asia. “It is a proud moment for all of us at PMI,” said Charles Bendotti, PMI Senior Vice President, People and Culture. “Our success as a company relies on the men and women who come to work every day with a passion to achieve, and a willingness to learn, grow, and
Another Victory for SPI in Stolichnaya Trademark Dispute16.2.2018 10:01 | Tiedote
On February 5, 2018, in Linz, SPI Group achieved yet another significant legal victory in its long-running dispute with Russian state-owned entity Federal Treasury Enterprise Sojuzplodoimport (FKP or FTE) over the ownership of SPI Group’s Stolichnaya and Moskovskaya trademarks. The Appellate Court of Linz ruled in favour of SPI Group, confirming their ownership of both trademarks in Austria. In its decision, the Austrian Appellate Court held that the Dutch interim judgments as well as the later Dutch judgments do not have any binding effect on the Austrian proceedings. The Austrian Court also: rejected the Dutch Courts’ approach that an invalidity of the Russian privatization would not be subject to any limitation period; noted that the approach used by the Dutch Courts’ ignores the fact that the privatization had for many years been considered by all persons involved, including the Russian State, as legal and had been implemented and “lived” as such, until the change of political powe
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme